 |
JOURNAL TOOLS |
| Publishing options |
| eTOC |
| To subscribe |
| Submit an article |
| Recommend to your librarian |
ARTICLE TOOLS |
| Publication history |
| Reprints |
| Permissions |
| Cite this article as |
| Share |
YOUR ACCOUNT
YOUR ORDERS
SHOPPING BASKET
Items: 0
Total amount: € 0,00
HOW TO ORDER
YOUR SUBSCRIPTIONS
YOUR ARTICLES
YOUR EBOOKS
COUPON
ACCESSIBILITY
EDITORIAL COMMENT Free access
Minerva Urology and Nephrology 2021 December;73(6):870-2
DOI: 10.23736/S2724-6051.21.04817-5
Copyright © 2021 EDIZIONI MINERVA MEDICA
language: English
Adverse event assessment in prostate cancer patients receiving androgen deprivation therapy: are we doing enough?
Fabio TURCO 1, Marcello TUCCI 2, Consuelo BUTTIGLIERO 1 ✉
1 Division of Medical Oncology, Department of Oncology, San Luigi Gonzaga Hospital, University of Turin, Orbassano, Turin, Italy; 2 Department of Medical Oncology, Cardinal Massaia Hospital, Asti, Italy